Closed tender

HPV Self-sampling Cost Effectiveness Model

Details

Buyer: Department of Health and Social Care
Value: £250,000
Topic: Research and development services and related consultancy services
Published: 15 July 2024
Submission: 18 August 2024
Source: uk:find_a_tender

Tender description

The Department of Health and Social Care has appointed an experienced supplier to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. Lot 1: The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV. The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion. Contract term: 18 months with the option to extend for a period of up to 6 months. Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT). Lot 1: The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV. The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion. Contract term: 18 months with the option to extend for a period of up to 6 months. Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT).

Timeline

Completed: Tender published15 July 2024
Current notice
Completed: Submission date18 August 2024

About the buyer

The Department of Health and Social Care sets health and social care policy for England, and buys as a central healthcare organisation through contracts tiered by value. Suppliers register on Atamis, the department's e-tendering portal, to see live opportunities. Larger contracts also appear on Find a Tender once government thresholds are passed. Much of this procurement flows through framework agreements and the Crown Commercial Service. Every contract carries a 30-day payment term under the Procurement Act 2023.

UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.

Over the past 5 years, most of the Department of Health and Social Care's contract awards have been in business services, IT services and health and social work.

Relevant CPV codes

73000000 · Research and development services and related consultancy services

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@department-of-health-and-social-care.gov
Commercial Director	+44 •••• ••••••	••••••••@department-of-health-and-social-care.gov
Procurement Manager	+44 •••• ••••••	••••••••@department-of-health-and-social-care.gov
Category Lead	+44 •••• ••••••	••••••••@department-of-health-and-social-care.gov
Senior Buyer	+44 •••• ••••••	••••••••@department-of-health-and-social-care.gov
Contracts Manager	+44 •••• ••••••	••••••••@department-of-health-and-social-care.gov